| pubmed-article:11257652 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0205312 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0032246 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0041365 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0441800 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C1441616 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0376249 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C1513354 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:11257652 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:11257652 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11257652 | pubmed:dateCreated | 2001-3-21 | lld:pubmed |
| pubmed-article:11257652 | pubmed:abstractText | We studied 363 patients with stage Ta bladder tumors during long-term followup who were classified according to the 1998 WHO and International Society of Urological Pathology consensus classifications. We determine whether various immunohistochemical and molecular markers could predict tumor progression. | lld:pubmed |
| pubmed-article:11257652 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11257652 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11257652 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11257652 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11257652 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11257652 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11257652 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:BuschCC | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:HedelinHH | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:WesterKK | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:JohanssonS... | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:HolmängSS | lld:pubmed |
| pubmed-article:11257652 | pubmed:author | pubmed-author:AndiusPP | lld:pubmed |
| pubmed-article:11257652 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11257652 | pubmed:volume | 165 | lld:pubmed |
| pubmed-article:11257652 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11257652 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11257652 | pubmed:pagination | 1124-8; discussion 1128-30 | lld:pubmed |
| pubmed-article:11257652 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:meshHeading | pubmed-meshheading:11257652... | lld:pubmed |
| pubmed-article:11257652 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11257652 | pubmed:articleTitle | Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. | lld:pubmed |
| pubmed-article:11257652 | pubmed:affiliation | Department of Urology, Sahlgrenska University Hospital, Göteborg, Sweden. | lld:pubmed |
| pubmed-article:11257652 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11257652 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11257652 | lld:pubmed |
